GlassScriptPhysician profile
Adam O Ham
NPI 1669781019
$1,382.75
in general payments reported to CMS, 2019-2025
18 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $243 · 2021: $67.23 · 2023: $85.07 · 2024: $325 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $292.36 | 2019-2023 | |
| Abbvie INC. | $274.17 | 2023-2024 | |
| Aerie Pharmaceuticals, INC. | $153.93 | 2019 | |
| Sun Pharmaceutical Industries INC. | $90.23 | 2019-2025 | |
| Dompe US, INC. | $86.29 | 2024-2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $77.60 | 2020-2024 | |
| Sight Sciences, INC. | $76.44 | 2019-2020 | |
| Rxsight INC | $46.88 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Coopervision INC. | $42.31 | 2019-2021 | |
| Shire North American Group INC | $40.83 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $38.48 | 2020 | |
| Alcon Vision LLC | $37.23 | 2019 | |
| Amgen INC. | $28.10 | 2024 | Tepezza |
| Allergan, INC. | $27.40 | 2019-2021 | |
| Biotissue Holdings INC. | $24.54 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $20.04 | 2025 | Miebo, Xiidra |
| Kala Pharmaceuticals, INC. | $13.87 | 2019 | |
| Eyevance Pharmaceuticals LLC | $12.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Ham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.